Movement Alert|FormFactor Falls 5.19% in Regular Trading, Profit-Taking Pressure Persists as Semiconductor Equipment Sector Weakens Again

Market Focus06-04

On June 4, FormFactor declined 5.19% in regular trading, trading at $119.81/share, with trading volume of $15.25 million, extending its recent pullback trend.

On the news front, the decline is primarily attributed to continued profit-taking following the company's strong Q1 earnings and renewed weakness across the semiconductor equipment sector. FormFactor previously reported Q1 revenue of $230 million with gross margin improving 5.1 percentage points sequentially to 49.0%, and raised its Q2 guidance. The stock surged to approximately $138 after the earnings release in late May but has since faced persistent selling pressure as investors locked in gains.

Meanwhile, the semiconductor equipment sector experienced broad-based weakness, with Lam Research down 4.57%, Teradyne down 4.20%, KLA-Tencor down 3.38%, Applied Materials down 2.67%, and ASML down 2.27%. This systemic sector decline further amplified FormFactor's downside pressure, compounding the individual stock's profit-taking dynamics.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment